| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
10,844,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
390,809 |
Avg
Vol: |
389,723 |
| 52
Week Range: |
$11.5 - $11.5 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Delivery |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kasnet Stephen G |
Director |
– • – |
2010-09-15 |
4 |
A |
$0.01 |
$280 |
D/D |
28,037 |
153,018 |
|
- |
|
| Andrews Valerie Lynne |
Director |
– • – |
2010-09-15 |
4 |
A |
$0.01 |
$280 |
D/D |
28,037 |
57,326 |
|
- |
|
| Campbell Anthony R |
|
– – – |
2010-09-13 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
3,108,097 |
|
- |
|
| Campbell Anthony R |
|
– – – |
2010-09-13 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
111,368 |
|
- |
|
| Csimma Cristina |
Director |
– • – |
2010-09-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,037 |
|
- |
|
| Wilkinson Fred |
Director |
– • • |
2010-07-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
11,200,000 |
|
- |
|
| Wilkinson Fred |
Director |
– • • |
2010-07-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
70,000 |
|
- |
|
| Watson Pharmaceuticals Inc |
10% Owner |
– – • |
2010-07-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
11,200,000 |
|
- |
|
| Coventry Acquisition, Inc. |
10% Owner |
– – • |
2010-07-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,200,000 |
|
- |
|
| Andrews Valerie Lynne |
Director |
– • – |
2010-07-02 |
4 |
D |
$1.03 |
$7,923 |
D/D |
(7,692) |
29,289 |
|
- |
|
| Campbell Anthony R |
Director |
– • – |
2010-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
925,926 |
10,362 |
|
- |
|
| Oskowitz Selwyn P |
Director |
– • – |
2010-07-02 |
4 |
D |
$1.03 |
$7,923 |
D/D |
(7,692) |
32,989 |
|
- |
|
| Mcgrane Michael |
Senior VP & General Counsel |
• – – |
2010-05-14 |
4 |
D |
$1.14 |
$784 |
D/D |
(688) |
89,761 |
|
- |
|
| Condella Frank Jr |
Interim CEO |
• • – |
2010-03-15 |
4 |
B |
$1.12 |
$112,150 |
D/D |
100,000 |
162,764 |
2.81 |
- |
|
| Mills Robert S |
President & COO |
• • – |
2010-03-11 |
4 |
D |
$1.06 |
$2,544 |
D/D |
(2,400) |
101,800 |
|
- |
|
| Mcgrane Michael |
Senior VP & General Counsel |
• – – |
2010-03-11 |
4 |
D |
$1.06 |
$1,855 |
D/D |
(1,750) |
90,449 |
|
- |
|
| Mills Robert S |
President & CEO |
• • – |
2010-03-03 |
4 |
D |
$1.35 |
$3,240 |
D/D |
(2,400) |
104,200 |
|
- |
|
| Mcgrane Michael |
Senior VP & General Counsel |
• – – |
2010-03-03 |
4 |
D |
$1.35 |
$2,363 |
D/D |
(1,750) |
92,199 |
|
- |
|
| Mills Robert S |
President & COO |
• • – |
2010-03-01 |
4 |
D |
$1.30 |
$2,600 |
D/D |
(2,000) |
106,600 |
|
- |
|
| Oskowitz Selwyn P |
Director |
– • – |
2009-11-13 |
4 |
B |
$0.99 |
$693 |
D/D |
700 |
40,681 |
2.31 |
- |
|
| Kasnet Stephen G |
Director |
– • – |
2009-11-11 |
4 |
B |
$0.99 |
$9,885 |
D/D |
10,000 |
124,981 |
2.39 |
- |
|
| Oskowitz Selwyn P |
Director |
– • – |
2009-11-10 |
4 |
B |
$0.85 |
$848 |
D/D |
1,000 |
39,981 |
2.31 |
- |
|
| Kasnet Stephen G |
Director |
– • – |
2009-11-09 |
4 |
B |
$0.85 |
$34,104 |
D/D |
40,000 |
114,981 |
2.39 |
- |
|
| Gyenes Lawrence A |
Senior Vice Prsident & CFO |
• – – |
2009-11-09 |
4 |
B |
$0.87 |
$43,285 |
D/D |
50,000 |
50,000 |
2.74 |
- |
|
| Condella Frank Jr |
Director |
– • – |
2009-10-01 |
4 |
A |
$0.01 |
$120 |
D/D |
12,000 |
62,764 |
|
- |
|
245 Records found
|
|
Page 5 of 10 |
|
|
